These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1325886

  • 1. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
    Murohara Y, Johnston CI.
    Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
    [Abstract] [Full Text] [Related]

  • 2. Prolonged neutral endopeptidase inhibition in heart failure.
    Helin K, Tikkanen I, Tikkanen T, Saijonmaa O, Sybertz EJ, Vemulapalli S, Sariola H, Fyhrquist F.
    Eur J Pharmacol; 1991 May 30; 198(1):23-30. PubMed ID: 1655477
    [Abstract] [Full Text] [Related]

  • 3. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
    Tikkanen I, Helin K, Tikkanen T, Sybertz EJ, Vemulapalli S, Sariola H, Näveri H, Fyhrquist F.
    J Pharmacol Exp Ther; 1990 Aug 30; 254(2):641-5. PubMed ID: 2143536
    [Abstract] [Full Text] [Related]

  • 4. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
    Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, Richards AM.
    Am J Physiol; 1997 Nov 30; 273(5):H2372-9. PubMed ID: 9374774
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
    Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H, Sybertz E.
    J Cardiovasc Pharmacol; 1992 Apr 30; 19(4):635-40. PubMed ID: 1380608
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
    Rademaker MT, Fitzpatrick MA, Charles CJ, Richards AM, Nicholls MG, Espiner EA, Sybertz E.
    J Cardiovasc Pharmacol; 1996 Mar 30; 27(3):439-46. PubMed ID: 8907807
    [Abstract] [Full Text] [Related]

  • 10. Increased expression of renal neutral endopeptidase in severe heart failure.
    Knecht M, Pagel I, Langenickel T, Philipp S, Scheuermann-Freestone M, Willnow T, Bruemmer D, Graf K, Dietz R, Willenbrock R.
    Life Sci; 2002 Oct 25; 71(23):2701-12. PubMed ID: 12383878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
    Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG, Richards AM.
    Hypertension; 2002 Jan 25; 39(1):93-8. PubMed ID: 11799085
    [Abstract] [Full Text] [Related]

  • 14. [Functional compartmentation of the endocrine action of cardiac natriuretic peptides].
    Haloui M, Arnal JF, Pham I, Gonzalez W, Lyoussi B, Michel JB.
    Ann Endocrinol (Paris); 2000 Feb 25; 61(1):32-40. PubMed ID: 10790590
    [Abstract] [Full Text] [Related]

  • 15. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL, Stevens TL, Cataliotti A, Schirger JA, Borgeson DD, Redfield MM, Luchner A, Burnett JC.
    Kidney Int; 2005 May 25; 67(5):1723-30. PubMed ID: 15840018
    [Abstract] [Full Text] [Related]

  • 16. The role of neutral endopeptidase in dogs with evolving congestive heart failure.
    Margulies KB, Barclay PL, Burnett JC.
    Circulation; 1995 Apr 01; 91(7):2036-42. PubMed ID: 7895362
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Fennell SA, Cheung HS, Rogers WL.
    Cardiovasc Res; 1993 Jun 01; 27(6):1015-23. PubMed ID: 8221758
    [Abstract] [Full Text] [Related]

  • 19. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
    Willenbrock R, Scheuermann M, Höhnel K, Luft FC, Dietz R.
    Hypertension; 1996 Jun 01; 27(6):1259-66. PubMed ID: 8641733
    [Abstract] [Full Text] [Related]

  • 20. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
    Pham I, el Amrani AI, Fournié-Zaluski MC, Corvol P, Roques B, Michel JB.
    J Cardiovasc Pharmacol; 1992 Dec 01; 20(6):847-57. PubMed ID: 1282584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.